Enzymatica published its Q2 2026 quarterly report
Net sales fell to SEK 7.1 million, with operating loss improved to SEK -12.6 million.
See the latest news and media coverage for Enzymatica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of enzyme-based viral and microbial defenses
enzymatica.comLast updated
In short: Enzymatica appointed Sana Alajmovic as CEO and signed a strategic partnership with STADA while reporting mixed financial results for 2026.
Net sales fell to SEK 7.1 million, with operating loss improved to SEK -12.6 million.
The notice concerns presentation of exploratory analyses in the 2023 Berlin II article, not study conduct or data validity.
Joakim Tingström Nordin will focus on strengthening ColdZyme's visibility and availability ahead of the cold season.
Resolutions include adopting financial statements, no dividend, board re-elections, auditor appointment, remuneration, and share issue authorization.
Enzymatica publ AB will release its next earnings report on Oct 29, 2026.
Second quarter· Net sales reached SEK 7,1 (8.3) million.· The operating result totaled SEK -12.6 (-14.9) million.· Earnings per share, basic and diluted, were SEK...
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail...
The agreement marks an important breakthrough for Enzymatica and opens opportunities in one of Europe's largest self-care markets. Net sales for the quarter amounted to...
Track Enzymatica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.